Boehringer Ingelheim Animal Health: vaccines and medicines
Boehringer Ingelheim's Animal Health division had net sales of EUR 4.875 billion in 2025 from vaccines and medicines for livestock, horses and pets.
Boehringer Ingelheim is a German pharmaceutical group whose Animal Health division makes vaccines and medicines for livestock, horses and companion animals.
Germany · Animal Health business of Boehringer Ingelheim
Boehringer Ingelheim is a German pharmaceutical group with a substantial Animal Health division alongside its human pharmaceutical business. The division's livestock portfolio covers the prevention and treatment of disease in pigs, ruminants and poultry. It also serves horses and companion animals, so its veterinary business reaches well beyond food production.
For livestock farms, the main products are vaccines and medicines used within herd and flock health programmes. Vaccines build immunity before disease pressure peaks, which reduces losses, treatment costs and antibiotic use. A prevention programme is typically built with the farm veterinarian around the disease history, test results and production routines of the unit, along with practical points such as delivery, cold storage and how health and production results are measured.
Size of the business
Boehringer Ingelheim's Animal Health net sales were EUR 4.875 billion in 2025, covering the full animal health portfolio and not the human pharmaceutical business.
What does the company offer?
Boehringer Ingelheim Animal Health offers veterinary vaccines and medicines, solutions for pigs, ruminants and poultry, and a wider portfolio for horses and companion animals.
How should a buyer make contact?
Sales are organised by country and business unit, and the company website lists the local contacts for each market. Enquiries usually set out the intended use, the scale of the operation and the timing.
The world’s largest agricultural companies
